Tilray Brands (TLRY) is expanding its hemp-derived Delta-9 THC beverage portfolio with new 10mg offerings from its Fizzy Jane’s and Happy Flower brands. The rollout adds higher-dose versions of the popular 5mg drinks, catering to consumers seeking a more robust experience while maintaining the same low-calorie, fruit-forward profiles.
Fizzy Jane’s, launched this spring in several Southeastern states, now offers Vanilla, Blood Orange, and Lemon Lime seltzers in 10mg cans, retailing at $17.99 for a four-pack. Happy Flower’s new “Super Bloom” collection includes 10mg versions of its Margarita, Strawberry Daiquiri, and Peach Bellini canned cocktails, alongside new variety packs in both 5mg and 10mg formats.
The products are now available online and in expanded retail markets, including Total Wine & More and ABC Fine Wine & Spirits. Tilray’s expansion comes as shares surged 20% this morning, fueled by a Wall Street Journal report on August 8, that former President Donald Trump is considering reclassifying marijuana as a Schedule III substance under federal law, a potential catalyst for the cannabis sector that has shares of Tilray up more than 75% this week.
The post Tilray Expands THC Beverage Lineup With New 10mg Options Amid Cannabis Rescheduling Buzz appeared first on PRISM MarketView.
